BRIEF-LeonaBio Enrolls 500th Subject In Phase 3 Elaine-3 Trial For Lasofoxifene With Abemaciclib - SEC Filing
LONA•LeonaBio enrolls 500th subject in Phase 3 Elaine-3 trial
Aug. 26 (Reuters) - LeonaBio Inc. LONA.O:
- LeonaBio enrolls 500th subject in Phase 3 Elaine-3 trial for lasofoxifene with abemaciclib - SEC filing
Source text: []
Further company coverage: LONA.O
